Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting

Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting

Doxorubicin (DOX), a widely used drug in cancer chemotherapy, induces cell death via multiple intracellular interactions, generating reactive oxygen species and DNA-adducted configurations that induce apoptosis, topoisomerase II inhibition, and histone eviction. Despite its wide therapeutic efficacy...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Jihoon Lee, Min-Koo Choi, Im-Sook Song
Format:	Artikel
Sprache:	English
Veröffentlicht:	MDPI AG 2023-05-01
Schriftenreihe:	Pharmaceuticals
Schlagworte:	doxorubicin (DOX) formulation strategy drug resistance oral formulation
Online Zugang:	https://www.mdpi.com/1424-8247/16/6/802

Ähnliche Einträge

Molecular mechanisms associated with the chemoprotective role of protocatechuic acid and its potential benefits in the amelioration of doxorubicin-induced cardiotoxicity: A review
von: Edozie S. Okpara, et al.
Veröffentlicht: (2022-01-01)

UHPLC-MS/MS Assay for Quantification of Legubicin, a Novel Doxorubicin-Based Legumain-Activated Prodrug, and Its Application to Pharmacokinetic and Tissue Distribution Studies
von: Liyuan Ma, et al.
Veröffentlicht: (2024-02-01)

Salvage Chemotherapy in Recurrent Cervical Cancer With Biweekly Pegylated Liposomal Doxorubicin (Lipo-Dox)
von: Jen-Ruei Chen, et al.
Veröffentlicht: (2008-09-01)

Targeting mitochondrial dynamics proteins for the treatment of doxorubicin-induced cardiotoxicity
von: Rui Chen, et al.
Veröffentlicht: (2023-08-01)

Quantitative analysis of doxorubicin hydrochloride and arterolane maleate by mid IR spectroscopy using transmission and reflectance modes
von: Ranju Bansal, et al.
Veröffentlicht: (2021-04-01)

The influence of strategy formulation practices on the perceived financial performance of small and medium enterprises: The Zimbabwean experience
von: Mugove Mashingaidze, et al.
Veröffentlicht: (2021-05-01)

Comparison of the Pharmacokinetics, Bioequivalence and Safety of Aqueous Progesterone Formulation Administered as either Intramuscular or Subcutaneous Injection versus Oil-based Progesterone Formulation Administered as Intramuscular Injection: A Randomised Study
von: Sonal Mehta, et al.
Veröffentlicht: (2023-05-01)

DOX-Vit D, a Novel Doxorubicin Delivery Approach, Inhibits Human Osteosarcoma Cell Proliferation by Inducing Apoptosis While Inhibiting Akt and mTOR Signaling Pathways
von: Zaid H. Maayah, et al.
Veröffentlicht: (2018-09-01)

Recent Formulation Advances and Therapeutic Usefulness of Orally Disintegrating Tablets (ODTs)
von: Maimoona Chinwala
Veröffentlicht: (2020-10-01)

An Alternative Source of Biopesticides and Improvement in Their Formulation—Recent Advances
von: Dragana Šunjka, et al.
Veröffentlicht: (2022-11-01)

A clinically relevant combination treatment with doxorubicin and cyclophosphamide does not induce hepatotoxicity in C57BL/6J mice
von: Satyanarayana R Pondugula, et al.
Veröffentlicht: (2021-12-01)

Allicin and L-carnitine as Preventive Agents Against Doxorubicin-induced Cardiac Damage in Rats
von: Ahmed Soliman, et al.
Veröffentlicht: (2024-08-01)

Effect of Alkaline Conditions on Forming an Effective G4.0 PAMAM Complex with Doxorubicin
von: Magdalena Szota, et al.
Veröffentlicht: (2023-03-01)

What does Pesticide Formulation Have to Do with Anything?
von: Laurie Ann Hurner
Veröffentlicht: (2016-08-01)

EFFECT OF THE C60 FULLERENE, DOXORUBICIN AND THEIR COMPLEX ON CANCER AND NORMAL CELLS OF BALB/c MICE
von: Prylutska S. V., et al.
Veröffentlicht: (2014-02-01)

Research Progress on Oral Nano-formulation to Deliver Astaxanthin
von: Chen ZHONG, et al.
Veröffentlicht: (2024-05-01)

Liposomal Formulations for Nose-to-Brain Delivery: Recent Advances and Future Perspectives
von: Soon-Seok Hong, et al.
Veröffentlicht: (2019-10-01)

Hesperidin as a preventive resistance agent in MCF–7 breast cancer cells line resistance to doxorubicin
von: Rifki Febriansah, et al.
Veröffentlicht: (2014-03-01)

Melatonin Restores Autophagic Flux by Activating the Sirt3/TFEB Signaling Pathway to Attenuate Doxorubicin-Induced Cardiomyopathy
von: Yanyan Ma, et al.
Veröffentlicht: (2023-09-01)

Metacommunication in the judiciary field: formulations. A proposal for cataloging and an approach to facework in institutional contexts
von: Laura Mariottini
Veröffentlicht: (2015-12-01)

Recent Advances in Propranolol Hydrochloride Formulations for the Treatment of Infantile Hemangiomas
von: Ren L, et al.
Veröffentlicht: (2025-02-01)

90-Days Repeated Dose Oral Toxicity Study of Sharbat-e-Deenar (A Hepatoprotective Unani Herbal Formulation)
von: Gulam Mohammed Husain, et al.
Veröffentlicht: (2021-03-01)

Exploitation of enrofloxacin-loaded docosanoic acid solid lipid nanoparticle suspension as oral and intramuscular sustained release formulations for pig
von: Yanfei Tao, et al.
Veröffentlicht: (2019-01-01)

A Novel Berberine–Glycyrrhizic Acid Complex Formulation Enhanced the Prevention Effect to Doxorubicin-Induced Cardiotoxicity by Pharmacokinetic Modulation of Berberine in Rats
von: Shichang Zhang, et al.
Veröffentlicht: (2022-07-01)

Development of Strategic Plan (Formulation, Implementation and Evaluation) of Physical Education in Lorestan Province by SWOT Approach
von: ahmadreza azizi, et al.
Veröffentlicht: (2020-06-01)

DHP107, a novel oral paclitaxel formulation induces less peripheral neuropathic pain and pain-related molecular alteration than intravenous paclitaxel preparation in rat
von: Md. Mahbubur Rahman, et al.
Veröffentlicht: (2019-08-01)

A clinical study to compare the efficacy and safety of pregabalin sustained release formulation with pregabalin immediate release formulation in patients of diabetic peripheral neuropathic pain
von: A Srivastava, et al.
Veröffentlicht: (2012-01-01)

Advances in Yeast Probiotic Production and Formulation for Preventative Health
von: Ghaneshree Moonsamy, et al.
Veröffentlicht: (2024-11-01)

Study of Oncolytic Virus Preservation and Formulation
von: Lina Pan, et al.
Veröffentlicht: (2023-06-01)

Pharmacokinetic and pharmacodynamic evaluation according to absorption differences in three formulations of ibuprofen
von: Shin D, et al.
Veröffentlicht: (2017-01-01)

Identification of co-regulated genes associated with doxorubicin resistance in the MCF-7/ADR cancer cell line
von: Ali Miri, et al.
Veröffentlicht: (2023-06-01)

Study of Marketing Strategy Formulation at Ok Clean Laundry using SWOT Analysis
von: Awal Muhammad, et al.
Veröffentlicht: (2022-01-01)

Influence of Differing Analgesic Formulations of Aspirin on Pharmacokinetic Parameters
von: Kunal Kanani, et al.
Veröffentlicht: (2015-08-01)

Inflammatory Reprogramming Mediates Changes in Three-Dimensional Strain Capacity and Cardiac Function in Beagle Dogs with Doxorubicin-Related Cardiomyopathy
von: Yifan Chen, et al.
Veröffentlicht: (2024-02-01)

Formulation Patents and Dermatology and Obviousness
von: Josephine Liu, et al.
Veröffentlicht: (2011-11-01)

Effectiveness of polyherbal formulations for the treatment of type 2 Diabetes mellitus - A systematic review and meta-analysis
von: Renuka Suvarna, et al.
Veröffentlicht: (2021-01-01)

Recent Advances in Nano-Formulations for Skin Wound Repair Applications
von: Lin Y, et al.
Veröffentlicht: (2022-08-01)

Recent Advances in ROS-Sensitive Nano-Formulations for Atherosclerosis Applications
von: Hao Ji, et al.
Veröffentlicht: (2021-09-01)

Doxorubicin/Nucleophosmin Binding Protein-Conjugated Nanoparticle Enhances Anti-leukemia Activity in Acute Lymphoblastic Leukemia Cells in vitro and in vivo
von: Donghui Gan, et al.
Veröffentlicht: (2021-05-01)

Strategic Management Roadmap: Formulation, Implementation, and Evaluation to Develop Islamic Higher Education Institution
von: Junaidah Junaidah, et al.
Veröffentlicht: (2020-12-01)